Study Data – Electronic Records Useful in Predicting Patients with Low Back Pain

by / Thursday, 31 March 2016 /

A study in Pain Research & Management suggests that data from electronic health records (EHRs) could be used to develop a predictive model for patients likely to develop low back pain (LBP).   In many cases, the researchers acknowledge, pain episodes and flare-ups naturally remit and recur in an episodic manner, and patients can engage in self-care and activity avoidance during those flare-ups to minimize the impact.   “However, for a substantial minority of patients, the pain episodes become more frequent, more intense, or increase in duration, and eventually progress to a more severe disease stage with consequences for treatment response, mental health, physical functioning, and utilization of health care,” the study authors note.

But are there enough pain signals within routinely collected clinical data within EHRs to predict future utilization patterns?   The researchers used a database maintained by Geisinger Health System to develop a series of logistic regression models to predict who will be a high-cost patient (defined as top 30% of the cost distribution) at each of the first 3 LBP visits. High cost was defined as any patient who used care over the subsequent 12 months that was greater than $1,176, the 70th percentile of the distribution. They found that, with a high degree of variability, they were able to fairly accurately predict with patients would become high utilizers of healthcare services.

Some of the more interesting study findings:

·      Men are more likely to become expensive than women

·      Patients receiving workers’ compensation as their primary payer type, had higher use of prescription opioids, or were smokers before their first LBP visit were more likely to become expensive.

·      Patients whose first encounter was with a primary care physician were less likely to become expensive than those who received their first LBP care elsewhere.

Some of the limitations of the study include that it only measured those who had at least one year of follow-up after the first LBP visit. “This may have biased the sample selection process because patients who did not meet this criterion may have had systematically less severe LBP,” the researchers note. Second, not all of the data used by the researchers is available in all EHRs—including the financial variables.   Still, they argue that their model allows the potential to identify potentially expensive patients in real time before they become truly expensive.

That is a tantalizing notion for managed care organizations, certainly, but also has potentially substantial positive benefit for future pain patients. “As the era of electronic medical records move beyond its current infancy, however, EHR-based predictive modelling strategies, such as the one presented herein, are likely to become more feasible and commonplace,” the researchers conclude.

Life Sciences delivers a multitude of orthotic treatment options to address one of the most costly systemic ailments in the world, chronic low back and neck pain. Our advanced solution begins with the Integrity Spinal Care System (ISCS) ™ and its proprietary iELCiPS Technology™. The ISCS non-surgical spinal decompression modality systems are engineered to provide pain relief for compressive and degenerative conditions of the spine. Specifically, conditions that may be treated include: neck pain and back pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.

As a compliment to the ISCS, Integrity offers the very effective Integrity Gel Support Brace™. Our advanced lumbar support brace is a fitting compliment to non-surgical spinal decompression therapy and was designed as an adjunct therapy for those suffering from back pain due to disc related conditions. The Integrity Gel Support Brace may be used with or without Integrity’s non-surgical spinal decompression systems and is an excellent treatment option for the patient to use at home.

In addition, Integrity Life Sciences has been exclusively granted the use of all of the technology, products, US Patent and Trademark Offices assignments, logos and other forms of intellectual property that were created by Axiom Worldwide, INC under the leadership of Jim Gibson from Tampa, Florida. The agreement specifically includes the flagship product DRX9000™, its family of products, and all of its derivatives such as the DRX9000C. Integrity offers support for these products, which includes: sales, maintenance services, and repairs. Only Integrity Life Sciences is Registered with the US FDA as a Factory Authorized – Contract Manufacturer – for Axiom Worldwide and the DRX9000 True Non-Surgical Spinal Decompression Systems™

James Gibson, President of Integrity Life Sciences and Axiom Worldwide states “Our partners, in over 50 countries and territories, have the unique opportunity to present a cutting edge medical device, utilizing a clinically validated protocol that restores a patient’s quality of life non-surgically and without pharmaceutical or invasive intervention“. With a body of published clinical research from around the world will support and strengthen your sales presentation; members of our medical advisory board herald from prestigious institutions such as Johns-Hopkins and The Mayo Clinic just to name a few. In addition, partners will have confidence in a quality product that adheres to the stringent standards mandated by FDA, CE, and ISO. Sales, marketing, and technical training is offered in prestigious locations in Europe, Asia, the Middle East and throughout the United States.

Learn more @: or

Integrity Life Sciences, LLC and Axiom Worldwide, INC are privately held companies with global partners and shareholders USA based company with international partners located across the globe with a mission of “Restoring Integrity to the Spine™“.

For additional information please visit:

Elements as Published in: MD Magazine